La preeclampsia (PE) es una de las complicaciones obstétricas del embarazo. Constituye un problema de salud pública ya que incide en las tasas de morbilidad y mortalidad materno-perinatal a nivel mundial (1), de impacto más severo en países en desarrollo, donde existen otras causas que influyen en la mortalidad materna (2). Ésta es motivo de repercusiones económicas tanto para la familia como para el establecimiento de salud, por prolongadas hospitalizaciones.

Objective. To identify perinatal outcomes in pregnant women with advanced maternal age (EMA) treated at the NationalMaternal Perinatal Institute. Materials and methods. Observational, descriptive and retrospective study of 321 maternaloutgoings occurred during the period from January 1 to June 30, 2016.

The genitourinary syndrome of menopause clinically is evident 4 to 5 years after menopause, and objective changes arepresent in 25-50% of all postmenopausal women. The most frequent symptoms are vaginal dryness ( 75%), dyspareunia(38%), and vaginal itching, vaginal discharge and pain (15%); and the diagnosis is based on clinical criteria. The principlestherapeutic are based on the restoration of urogenital physiology and relief of symptoms; including non-hormonal / lubricanttherapeutic options, systemic hormonal therapy, local estrogen therapy and other alternatives. The genitourinary syndromeof menopause is one of the most important determinants of sexual function and urogenital health, with a significant impact onthe quality of life related to female health.

Objective. To identify perinatal outcomes in pregnant women with advanced maternal age (EMA) treated at the NationalMaternal Perinatal Institute. Materials and methods. Observational, descriptive and retrospective study of 321 maternaloutgoings occurred during the period from January 1 to June 30, 2016.

The genitourinary syndrome of menopause clinically is evident 4 to 5 years after menopause, and objective changes arepresent in 25-50% of all postmenopausal women. The most frequent symptoms are vaginal dryness ( 75%), dyspareunia(38%), and vaginal itching, vaginal discharge and pain (15%); and the diagnosis is based on clinical criteria. The principlestherapeutic are based on the restoration of urogenital physiology and relief of symptoms; including non-hormonal / lubricanttherapeutic options, systemic hormonal therapy, local estrogen therapy and other alternatives. The genitourinary syndromeof menopause is one of the most important determinants of sexual function and urogenital health, with a significant impact onthe quality of life related to female health.

Fetal growth restriction (RCF) is a clinical circumstance in which the fetus does not express its genetic potential for growth and as a final result a decrease in body weight occurs, which is below the 10th percentile for gestational age, in a selected growth curve. Among the etiological factors include: maternal, fetal and placental causes. It is classified as Precocious and late. The appropriate time for delivery is determined by gestational age and fetal condition.

Fetal growth restriction (RCF) is a clinical circumstance in which the fetus does not express its genetic potential for growth and as a final result a decrease in body weight occurs, which is below the 10th percentile for gestational age, in a selected growth curve. Among the etiological factors include: maternal, fetal and placental causes. It is classified as Precocious and late. The appropriate time for delivery is determined by gestational age and fetal condition.